PTPN1/2 Inhibition Remodels the Pulmonary Myeloid Landscape to Induce Alveolar Macrophage-Mediated Control of Lung Metastasis.
Metastasis remains the leading cause of cancer mortality, yet effective therapies for inhibiting and treating metastasis are limited. Therapeutic responses are influenced by organ-specific immune microenvironments, highlighting the need to develop strategies to pharmacologically modulate these niches. Here, using the c...